Telocytes in the Female Reproductive System: Current Knowledge, Challenges and Possible Clinical Applications

Submission deadline: 28 February 2023
Special Issue Editor
  • Ivan Varga, PhD
    Department of Histology and Embryology, Faculty of Medicine, Comenius University in Bratislava, Bratislava, Slovakia
    Interests: development and microscopic anatomy of the human lymphoid and female reproductive organs; ultrastructural characterization of the human mesenchymal stem cells and their application in regenerative medicine; reproductive biology; new trends in histology and embryology teaching
Special Issue Information

Dear Colleagues,

In 2005, a Romanian team of scientists led by Professor Popescu described “mysterious” interstitial telocyte cells in the ovary, uterine tubes, uterus, vagina, mammary gland, and placenta. The most concise and pertinent definition of telocytes is that they are cells with extremely long and thin cytoplasmic projections called telopodes, the length of which is only surpassed by nerve cell axons. The main functions of telocytes include the regulation of hormone-dependent processes, intercellular signaling, immune surveillance, microenvironmental maintenance, and the nursing of stem cells. Although it is not yet generally accepted that telocytes are a distinct cell population with characteristic morphological and functional features, several articles on this cell type have been published in prestigious journals such as Nature and Annals of the New York Academy of Sciences. Diseases may develop in situations where the telocytes are functionally or morphologically damaged. The most commonly described gynecological and obstetric diseases that have been associated with telocytes (i.e. "telocytopathies") include premature ovarian failure, endometriosis, ectopic pregnancy, infertility, preeclampsia, and even breast cancer. The common denominator in many of these conditions is that their etiopathogenesis is either completely obscure or only partially known. Although the exact role of telocytes in these conditions has yet to be determined, multiple lines of research suggest they may have future clinical applications for improving the diagnosis and treatment of many conditions. Finally, the contribution of telocytes to regenerative medicine and tissue engineering is a buregeoning research area.

Prof. Dr. Ivan Varga

Guest Editor

Keywords
telocytes
telocytopathies
female reproductive system
mammary gland
ovaries
placenta
uterine tubes
uterus
vagina
infertility
preeclampsia
ectopic pregnancy
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 1500 USD. Submitted manuscripts should be well formatted in good English.

Published Paper (1 Paper)
Back to top